Unknown PHASE2 INTERVENTIONAL 8-arm NCT02059616

A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension

A Randomized, Double-blind, Multi-center, PhaseⅡ Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Candesartan Cilexetil and Amlodipine Besylate for the Dose Selection in Patients With Essential Hypertension

Sponsor: HK inno.N Corporation

Conditions Essential Hypertension

Interventions Amlodipine 10mg Amlodipine 5mg Candesartan Cilexetil 8mg Candesartan cilexetil 16mg

Updated 7 times since 2017 Last updated: Apr 29, 2014 Started: Feb 28, 2014 Primary completion: Jun 30, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02059616, this PHASE2 trial focuses on Essential Hypertension and remains ongoing. Sponsored by HK inno.N Corporation, it has been updated 7 times since 2014, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Aug 2020 — Jan 2021 [monthly]

Unknown Status PHASE2

▶ Show 2 earlier versions

Jun 2018 — Aug 2020 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

HK inno.N Corporation

Data source: HK inno.N Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bundang, South Korea , Busan, South Korea , Daegu, South Korea , Daejeon, South Korea , Gwangju, South Korea , Ilsan, South Korea , Incheon, South Korea , Kyungki-do, South Korea , Pusan, South Korea , Seoul, South Korea and 2 more locations